Endoscopy News and Research

RSS

Bile duct cancer chosen as next indication for PCI Biotech

PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that it has chosen bileduct cancer as the next indication for the use of its PCI (photochemical internalisation) localised cancer therapy. In this indication PCI Biotech’s proprietary photosensitiser Amphinex® will be used in combination with the generic cytotoxic agent gemcitabine. The aim is to start the clinical Proof of Concept study within end of 1H 2013.

21 Aug 2012

Mayo Clinic receives approval for construction of new building on Phoenix campus

Mayo Clinic has been granted approval for construction of a 217,200 square-foot building on its Phoenix campus, a major expansion that will create a single-site, integrated Cancer Center. Mayo Clinic Cancer Center is the only National Cancer Institute-designated comprehensive cancer center with a multi-site, national presence, which allows us to serve a broad and diverse group of patients.

21 Aug 2012

Tofacitinib drug shows promise against moderate-to-severe ulcerative colitis

An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine.

16 Aug 2012

Palliative care on Scottish surgical wards needs improving

More than half of individuals with terminal gastrointestinal cancer on general surgical wards in Scotland do not undergo operative intervention on their final admission, show study results published in The Surgeon.

15 Aug 2012

New type of medical imaging could help doctors spot tumors more quickly

Scientists from the University of Southern California in Los Angeles and Washington University in St. Louis have developed a new type of medical imaging that gives doctors a new look at live internal organs.

14 Aug 2012

FUJIFILM releases FDR D-EVO 24x30cm Cesium Iodide flat panel detector at 40th AHRA

Today at the 40th Annual AHRA Meeting and Exposition, FUJIFILM Medical Systems U.S.A., Inc. announced the commercial availability of the FDR D-EVO 24x30cm Cesium Iodide flat panel detector, the latest addition to one of the most diverse family of DR products available today.

13 Aug 2012

Colonoscopy with polypectomy decreases colorectal cancer incidence and mortality

A study from researchers in Switzerland found that colonoscopy with polypectomy significantly reduces colorectal cancer incidence and colorectal cancer-related death in the general population.

25 Jul 2012

Endoscopy, better tissue sampling required to improve care for patients with oesophageal cancer

The world's largest review of all the evidence on the best way of managing and treating common pre-cancerous and cancerous conditions of the oesophagus (gullet) has found that good endoscopy equipment, more endoscopic surgery, and more tissue sampling are required to improve care for patients.

24 Jul 2012

Xlumena receives CE Mark approval to market AXIOS Stent and Delivery System

Xlumena, Inc. announces that it has received CE Mark approval to market its AXIOS Stent and Delivery System for biliary tract drainage.

18 Jul 2012

Tips to help minimize risks associated with acid reflux disease

While the overall death rates from several cancers such as breast and lung have gone down, there has been a meteoric rise in cases of esophageal cancer. Studies have shown that from 1975 to 2001, the incidence of esophageal adenocarcinoma rose approximately sixfold in the United States (from four to 23 cases per million), a relative increase greater than that for melanoma, breast, or prostate cancer.

17 Jul 2012

Study determines optimal screening strategy for gastric or stomach cancer

A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings could help reduce deaths from gastric cancer, which is the second most common cause of cancer-related mortality.

16 Jul 2012

Researchers discover HVEM’s unknown role in fighting off E. coli infections

Despite ongoing public health efforts, E. coli outbreaks continue to infiltrate the food supply, annually causing significant sickness and death throughout the world. But the research community is gaining ground. In a major finding, published today in the scientific journal Nature, researchers from the La Jolla Institute for Allergy & Immunology have discovered a molecule's previously unknown role in fighting off E. coli and other bacterial infections, a discovery that could lead to new ways to protect people from these dangerous microorganisms.

16 Jul 2012

FUJIFILM receives ONC-ATCB certification for Synapse MU 3.0 EHR technology

FUJIFILM Medical Systems U.S.A. announced today that Synapse MU 3.0, is 2011/2012 compliant and was certified as a Complete EHR on June 28, 2012 by the Certification Commission for Health Information Technology, an ONC-ATCB, in accordance with the applicable eligible provider certification criteria adopted by the Secretary of Health and Human Services.

9 Jul 2012

Cook Medical receives FDA clearance for Evolution Colonic Controlled-Release Stent

The U.S. Food and Drug Administration (FDA) has granted Cook Medical 510(k) clearance for the Evolution Colonic Controlled-Release Stent, Cook announced today.

9 Jul 2012

MDI and CSIRO ink tech deal for next generation production of 'Green Whistle'

Australian healthcare company Medical Developments International (MDI) and CSIRO have signed a technology deal to develop a new production process for the drug methoxyflurane - the pain-relieving ingredient used in Penthrox™ (commonly known as the green whistle).

9 Jul 2012

Under-performance of small bowel biopsy a major reason behind underdiagnosis of celiac disease

Under-performance of small bowel biopsy during endoscopy may be a major reason that celiac disease remains underdiagnosed in the United States, according to a new study published online recently in Gastrointestinal Endoscopy. Investigators at the Celiac Disease Center at Columbia University Medical Center (CUMC) found that the rate of small bowel biopsy is low in this country.

30 Jun 2012

Endoscopy News and Research

Bile duct cancer chosen as next indication for PCI Biotech

Mayo Clinic receives approval for construction of new building on Phoenix campus

Tofacitinib drug shows promise against moderate-to-severe ulcerative colitis

Palliative care on Scottish surgical wards needs improving

New type of medical imaging could help doctors spot tumors more quickly

FUJIFILM releases FDR D-EVO 24x30cm Cesium Iodide flat panel detector at 40th AHRA

Colonoscopy with polypectomy decreases colorectal cancer incidence and mortality

Endoscopy, better tissue sampling required to improve care for patients with oesophageal cancer

Xlumena receives CE Mark approval to market AXIOS Stent and Delivery System

Tips to help minimize risks associated with acid reflux disease

Study determines optimal screening strategy for gastric or stomach cancer

Researchers discover HVEM’s unknown role in fighting off E. coli infections

FUJIFILM receives ONC-ATCB certification for Synapse MU 3.0 EHR technology

Cook Medical receives FDA clearance for Evolution Colonic Controlled-Release Stent

MDI and CSIRO ink tech deal for next generation production of 'Green Whistle'

Under-performance of small bowel biopsy a major reason behind underdiagnosis of celiac disease

Rate of small bowel biopsy is low in the U.S.

Early pain relief surgery improves long-term chronic pancreatitis outcomes

Flat polyps may explain colorectal cancer screening discrepancy

Staff at Sheffield Teaching Hospitals shortlisted for more awards than any other trust in the country

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News